Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 427

2.

Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: comparison with chronoamperometry in SERT knockout mice.

Perez XA, Bianco LE, Andrews AM.

J Neurosci Methods. 2006 Jun 30;154(1-2):245-55. Epub 2006 Feb 10.

PMID:
16472867
3.

Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.

Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM.

J Neurosci Methods. 2004 Dec 30;140(1-2):81-92.

PMID:
15589338
4.

Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.

Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM.

J Neurosci Methods. 2004 Dec 30;140(1-2):169-81.

PMID:
15589347
5.

Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.

Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S.

Br J Pharmacol. 2005 Mar;144(5):695-702.

6.

Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.

Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, Lesch KP, Lu B, Murphy DL.

J Neurosci Res. 2005 Mar 15;79(6):756-71.

PMID:
15672416
7.

Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.

Hirano K, Seki T, Sakai N, Kato Y, Hashimoto H, Uchida S, Yamada S.

Brain Res. 2005 Aug 16;1053(1-2):154-61.

PMID:
16051196
8.

siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.

Thakker DR, Natt F, Hüsken D, van der Putten H, Maier R, Hoyer D, Cryan JF.

Mol Psychiatry. 2005 Aug;10(8):782-9, 714.

PMID:
15940298
10.

Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).

Ansah TA, Ramamoorthy S, Montañez S, Daws LC, Blakely RD.

J Pharmacol Exp Ther. 2003 Jun;305(3):956-65. Epub 2003 Mar 6.

11.

Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.

Lu NZ, Eshleman AJ, Janowsky A, Bethea CL.

Mol Psychiatry. 2003 Mar;8(3):353-60.

PMID:
12660809
12.

Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.

Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA.

Biol Psychiatry. 2003 Nov 15;54(10):960-71.

PMID:
14625138
13.

Pharmacological characterization and visualization of the glial serotonin transporter.

Inazu M, Takeda H, Ikoshi H, Sugisawa M, Uchida Y, Matsumiya T.

Neurochem Int. 2001 Jul;39(1):39-49.

PMID:
11311448
14.

Neuropharmacology of paroxetine.

Nemeroff CB, Owens MJ.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:8-18. Review.

PMID:
14566196
15.

Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.

Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A.

J Neurosci. 1999 Dec 1;19(23):10494-501.

19.

Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons.

Montañez S, Daws LC, Gould GG, Frazer A.

J Neurochem. 2003 Nov;87(4):861-7.

20.

Supplemental Content

Support Center